Skip to content
← All dividend stocks
HealthcareDrug Manufacturers - General

JNJ Dividend Calculator: Project Johnson & Johnson Dividend Income

Johnson & Johnson sits in a rare group of companies that have increased their dividend every year for more than six decades. That streak, built on pharmaceutical and medical-device cash flows, is why income investors treat JNJ as a core blue-chip holding.

The trade-off is a moderate starting yield rather than a high one. The long-run case rests on payout durability and consistent increases, not on maximizing income today.

Use this calculator to project JNJ income from a lump sum or regular contributions, toggle reinvestment, and solve backwards from a monthly target using current data.

Run JNJ in the calculatorCompare dividend ETFs

Data as of September 27, 2026 · Sources: Yahoo Finance and company filings.

Share price
$271.22
Dividend yield (TTM)
1.98%
TTM dividend / share
$5.28
Distribution frequency
Quarterly
Payout ratio
61%
Market cap
$653.6B
How much JNJ do you need for your income goal?

Capital required at the current 1.98% yield, before taxes and before accounting for future dividend growth or reinvestment.

Monthly incomeAnnual incomeCapital requiredApprox. shares
$500/month$6.0K$303.0K1,118
$1,000/month$12.0K$606.1K2,235
$2,000/month$24.0K$1.2M4,470
$3,000/month$36.0K$1.8M6,704
$5,000/month$60.0K$3.0M11,173
$10,000/month$120.0K$6.1M22,346

Estimates only. Yield, share price, and distributions change over time. Use the full calculator to model monthly contributions, dividend growth, taxes, and reinvestment.

How long to reach your JNJ income goal?

Years until projected dividend income first reaches each target, starting from zero with every distribution reinvested. Assumes today's 1.98% yield and dividend growth consistent with the fund's record; taxes and withdrawals are excluded.

Monthly contribution$500/month$1,000/month$2,000/month$5,000/month
$250/month16 yr20 yr23 yr27 yr
$500/month13 yr16 yr20 yr24 yr
$1,000/month10 yr13 yr16 yr21 yr

Projections assume a constant yield, dividend growth consistent with the holding's recent record, no price changes beyond its recent trend, and full reinvestment. Actual results will differ. Dividend income is shown before taxes.

Who JNJ is for
  • Income investors who prioritize dividend durability over headline yield
  • Long-term core positions in diversified portfolios
  • Taxable accounts, since most of the payout is qualified dividends
  • Investors building a rising income stream over decades
Trade-offs to understand
  • Moderate yield compared with high-yield sectors like tobacco or REITs
  • Payout growth depends on the drug pipeline and litigation outcomes
  • Quarterly distributions only

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

JNJ key facts
MetricValue
CompanyJohnson & Johnson
SectorHealthcare
IndustryDrug Manufacturers - General
TickerJNJ
Share price$271.22
Dividend yield (TTM)1.98%
Annual dividend / share$5.36
TTM distributions / share$5.28
Payout ratio61%
Distribution frequencyQuarterly
Market cap$653.6B

Figures are the latest available and change with price and company reporting. The payout ratio is omitted when reported earnings distort it above 120% — common for REITs and companies with large one-off charges. Historical performance is not a forecast.

JNJ dividend history and payout schedule
TTM / share
$5.28
Yield (TTM)
1.98%
Annual growth
4.8%
Pays in
February, May, August, November
Payment datePer share
August 25, 2026$1.34
May 26, 2026$1.34
February 24, 2026$1.30
November 25, 2025$1.30
August 26, 2025$1.30
May 27, 2025$1.30
February 18, 2025$1.24
November 26, 2024$1.24

Annual growth compares the latest twelve months of distributions with the twelve months ending four years earlier and is not a forecast. Past distributions can be reduced or suspended.

JNJ frequently asked questions

JNJ yields about 1.98% per year on a trailing basis at $271.22 per share. Its long dividend-increase streak is the headline feature; the starting yield is moderate because the share price has compounded alongside the payout.

At a 1.98% yield, $12,000 per year requires roughly $606.1K, or about 2,235 shares at $271.22. Regular contributions and dividend increases reduce the capital needed over time.

JNJ distributes quarterly, recently in February, May, August, November. The trailing twelve-month distribution totals about $5.28 per share. Most brokers can reinvest payments automatically through DRIP.

Comparing the latest twelve months of distributions with the twelve months ending four years earlier, JNJ's per-share payout has grown at roughly 4.8% per year. Increases have historically been modest but persistent; they are not guaranteed.

JNJ's payout is supported by a diversified pharmaceutical and medical-device business and a decades-long record of increases, which is why many income investors treat it as a conservative holding. No dividend is guaranteed — pipeline setbacks or large litigation costs can slow growth.

JNJ's distributions are generally qualified dividends, taxed at long-term capital gains rates in taxable accounts. Holding JNJ in an IRA or Roth removes the annual tax drag. Confirm your situation with a tax professional.

Investing $500 a month with all distributions reinvested, JNJ's projected dividend income reaches $1,000 a month in about 16 years. By then you would have contributed roughly $96.0K and the projected portfolio value would be about $334.2K. This assumes today's 1.98% yield and the growth assumptions shown in the calculator, with no taxes or withdrawals — projections, not guarantees.
Guides that go deeper
More stock calculators

Income goals

Disclaimer: This page is for educational purposes only and is not financial, investment, or tax advice. Data is sourced from Yahoo Finance and company filings and may be delayed or contain errors. Dividends are not guaranteed and can be reduced or suspended. Past performance is not indicative of future results. Always consult a qualified advisor before making investment decisions.